KuCoin Releases 2025 Annual Review: A Renewed Brand, a Year Built on Trust
PROVIDENCIALES, Turks and Caicos Islands, Dec. 30, 2025 /PRNewswire/ -- KuCoin today…
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 29, 2025 16:30 ET | Source: iRhythm SAN FRANCISCO, Dec. 29,…
Charles Winslow Completes Annual Internal Strategic Review at Lumena Intelligent Alliance Office
Jersey City, NJ, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Lumena Intelligent Alliance…
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 18, 2025 19:00 ET | Source: Mesa Laboratories, Inc. LAKEWOOD, Colo.,…
Xinhua Silk Road: Annual wine-themed folk culture festival held in E. China’s Jiangxi Province
BEIJING, Dec. 17, 2025 /PRNewswire/ -- A wine-themed folk culture festival kicked off…
GEDU Global Education Signs Agreement with United Nations Agency UNITAR during XXII CIFAL Annual Meeting in London
LONDON, Dec. 17, 2025 /PRNewswire/ -- UK-based education multinational GEDU Global Education has…
12TH ANNUAL WINTERNATIONAL EMBASSY SHOWCASE DRAWS 8,000 GUESTS
70 Embassies Unite to Celebrate Global Culture and Traditions at the Ronald…
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec.…
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc.…
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
